# Study of Pioglitazone in Sporadic Inclusion Body Myositis

> **NCT03440034** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 19 (actual)

## Conditions studied

- Myositis
- Inclusion Body Myositis
- Muscular Diseases
- Musculoskeletal Disease
- Neuromuscular Diseases
- Nervous System Diseases

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT03440034
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-22
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03440034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03440034, "Study of Pioglitazone in Sporadic Inclusion Body Myositis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03440034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*